Novartis Drug SigniforR Recommended by FDA Advisory Committee for Approval

Novartis drug SigniforR recommended by FDA advisory committee for approval

Filed under: drug treatment news 2010

Basel, November 7, 2012 – The US Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support of the use of Signifor R (pasireotide) for the treatment of patients with Cushing's …
Read more on Reuters

 

Expensive Drugs, Challenge to Tuberculosis Treatment in Nigeria

Filed under: drug treatment news 2010

Medical experts have warned that the trend should be quickly checked in order to forestall what they described as "imminent and total collapse of the efficacy of the available first-line drugs for TB treatment." According to Dr Taiwo Orelope, a medical …
Read more on AllAfrica.com

 

Clovis Oncology: This Treatment is Out of Reach

Filed under: drug treatment news 2010

Abraxane, a cancer treatment acquired in the 2010 deal, has shown to improve the delivery of chemotherapy to cancer cells in a late-stage study. On November 9, Celgene reported that the drug had improved survival in patients with pancreatic cancer, …
Read more on Wall St. Cheat Sheet